| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |